NasdaqGS - Nasdaq Real Time Price USD
Masimo Corporation (MASI)
171.97
+7.25
+(4.40%)
At close: June 6 at 4:00:01 PM EDT
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 8 | 8 | 8 | 8 |
Avg. Estimate | 1.22 | 1.13 | 4.97 | 5.41 |
Low Estimate | 1.2 | 1.05 | 4.9 | 5.21 |
High Estimate | 1.3 | 1.18 | 5.05 | 5.86 |
Year Ago EPS | 0.86 | 0.86 | 4.4 | 4.97 |
Revenue Estimate
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 8 | 8 | 9 | 9 |
Avg. Estimate | 368.65M | 369.56M | 1.52B | 1.64B |
Low Estimate | 367.3M | 365.8M | 1.51B | 1.62B |
High Estimate | 372.1M | 371.8M | 1.53B | 1.67B |
Year Ago Sales | 496.3M | 504.6M | 2.09B | 1.52B |
Sales Growth (year/est) | -25.72% | -26.76% | -27.49% | 7.79% |
Earnings History
Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
---|---|---|---|---|
EPS Est. | 0.76 | 0.84 | 1.42 | 1.21 |
EPS Actual | 0.86 | 0.86 | 1.8 | 1.36 |
Difference | 0.09 | 0.02 | 0.38 | 0.15 |
Surprise % | 12.42% | 2.79% | 26.32% | 12.51% |
EPS Trend
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | 1.22 | 1.13 | 4.97 | 5.41 |
7 Days Ago | 1.22 | 1.13 | 4.97 | 5.41 |
30 Days Ago | 1.25 | 1.27 | 5.25 | 5.89 |
60 Days Ago | 1.25 | 1.27 | 5.25 | 5.89 |
90 Days Ago | 1.25 | 1.27 | 5.25 | 5.89 |
EPS Revisions
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | 2 | -- | -- | -- |
Up Last 30 Days | 2 | -- | -- | -- |
Down Last 7 Days | 5 | 8 | 8 | 8 |
Down Last 30 Days | 5 | 8 | 8 | 8 |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
MASI | 42.15% | 31.69% | 13.07% | 8.74% |
S&P 500 | 13.13% | 2.46% | 7.55% | 14.08% |
Upgrades & Downgrades
Maintains | Raymond James: Outperform to Outperform | 5/7/2025 |
Reiterates | Piper Sandler: Overweight to Overweight | 5/7/2025 |
Maintains | Wells Fargo: Overweight to Overweight | 5/7/2025 |
Reiterates | Needham: Hold to Hold | 4/10/2025 |
Maintains | Piper Sandler: Overweight to Overweight | 2/26/2025 |
Maintains | Wells Fargo: Overweight to Overweight | 2/26/2025 |
Related Tickers
INSP Inspire Medical Systems, Inc.
136.02
+0.11%
PRCT PROCEPT BioRobotics Corporation
62.91
-3.29%
PODD Insulet Corporation
311.77
-1.70%
EW Edwards Lifesciences Corporation
77.52
-0.32%
DXCM DexCom, Inc.
86.67
+1.08%
PEN Penumbra, Inc.
258.90
+0.20%
BIO Bio-Rad Laboratories, Inc.
219.42
+0.05%
GKOS Glaukos Corporation
92.99
+0.32%
GMED Globus Medical, Inc.
59.92
+0.62%
NVCR NovoCure Limited
17.00
+3.34%